ArticleExperimental cell research2022

iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.

Junjie Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.